Konica Minolta Healthcare announced that it was awarded the No. 1 overall DR (digital radiography) User Satisfaction rating in the third quarter of 2016 by MD Buyline.

vRad (Virtual Radiologic) announced that it has implemented its first breast imaging Live Video Diagnostics solution site at the Center for Women’s Imaging at Medical Center Hospital (MCH) using Cisco technology.

A supplemental “boost” of radiation improves local control and provides an incremental benefit in decreasing breast cancer recurrence for patients with ductal carcinoma in situ (DCIS) who receive whole breast radiation therapy radiation (WBRT) following lumpectomy, according to new research. Researchers concluded that use of a radiation boost should be considered in DCIS patients who have life expectancies of 10 or more years following breast-conserving surgery and WBRT.

Toshiba America Medical Systems Inc. announced it will be displaying a wide array of diagnostic imaging technologies at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 2 in Chicago, including the latest advances in ultrasound.

People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet. The phase 3 randomized trial found that whole brain radiotherapy had no beneficial effect on length or quality of survival over treatment with steroids and other supportive care.

October 7, 2016 — ContextVision’s US PLUSView 2.0 technology for 2-D ultrasound image enhancement has been extended for ...

UCHealth (Colorado) has expanded their use of Riverain’s ClearRead Bone Suppression and ClearRead Confirm software to all five of their flagship hospitals. The expansion will ensure patients across the entire network benefit from the same tools designed to aid in more effective detection of lung disease, including lung cancer. Utilization of the ClearRead tools across UCHealth ensures patients and clinicians benefit from the technology independent of the imaging location within the network.

Elekta announced recently that its high-field magnetic resonance linear accelerator (MR-linac) was the focus of multiple presentations at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting, held Sept. 25 – 28 in Boston. Additional abstracts presented by members of Elekta’s MR-linac Consortium also highlighted the need for adaptation of radiation therapy to address moving tumors and nearby organs during treatment sessions. Naturally occurring physiological movements currently limit the ability to conform the treatment to the target and increase exposure of radiation to healthy tissues.